WHO Recommends Two New Medications For COVID-19 Treatment
Mohammad Ali (@ChaudhryMAli88) Published January 14, 2022 | 04:10 AM
MOSCOW (UrduPoint News / Sputnik - 14th January, 2022) The World Health Organization (WHO) Guideline Development Group recommended on Friday the use of two arthritis drugs called baricitinib and interleukin-6 (IL-6) in combination with corticosteroids to treat patients with severe or critical COVID-19.
"Today's recommendations are based on new evidence from seven trials involving over 4,000 patients with non-severe, severe, and critical covid-19 infection," the group said in the British Medical Journal.
Trials showed that a combination of corticosteroids with baricitinib and IL-6 - drugs of the Janus kinase inhibitor (JAK) group used to treat rheumatoid arthritis -� improves the survival rate and reduces the need for pulmonary ventilation, with no increased adverse effects.
"When both are available, they suggest choosing one based on cost, availability, and clinician experience. It is not recommended to use both drugs at the same time," the experts said.
Furthermore, the experts advised against using two other JAK inhibitors known as ruxolitinib and tofacitinib for COVID-19 patients in severe or critical condition, as limited trials have shown no benefit, with the possible occurrence of serious side effects.
The WHO's guideline update also recommended the use of monoclonal antibody drugs, such as sotrovimab and casirivimab/imdevimab, in patients with mild COVID-19, but only in those at the highest risk of hospitalization. The experts noted that there isn't sufficient evidence to recommend one variant of monoclonal antibodies treatment over another.
The updated guideline complements previous WHO recommendations on using IL-6 receptor blockers and systemic corticosteroids in patients with severe or critical COVID-19; conditional recommendations on the use of casirivimab/imdevimab (another monoclonal antibody treatment) in select patients; and against the use of convalescent plasma, ivermectin and hydroxychloroquine in patients regardless of disease severity.
Related Topics
Recent Stories
Russia targets Ukraine railways as Western aid due to arrive
Football: French Ligue 1 table
Miner Anglo American rejects BHP's near $39-billion takeover bid
115 held for selling roti at higher rate
New Zealand cricket CEO visits PSCA, expresses satisfaction over security arrang ..
NAB Lahore holds open court, promises compensations for victims
2 injured over money dispute
At least 10 people killed in Brazil fire: officials
'Transforming Punjab Agriculture' plan to help develop farm sector on modern lin ..
Chairman PRCS engages in humanitarian collaboration with ambassador of Morocco
US stocks rebound on tech earnings, London hits new record
Junta-led Burkina Faso suspends BBC, Voice of America for two weeks
More Stories From World
-
Russia targets Ukraine railways as Western aid due to arrive
3 minutes ago -
Miner Anglo American rejects BHP's near $39-billion takeover bid
15 minutes ago -
At least 10 people killed in Brazil fire: officials
11 minutes ago -
Junta-led Burkina Faso suspends BBC, Voice of America for two weeks
12 minutes ago -
Saudi to host top Arab, EU diplomats for Gaza talks: officials
15 minutes ago -
Kenya flood death toll since March climbs to 70: govt
10 minutes ago
-
US Fed's favored inflation measure accelerates in March
1 hour ago -
Kenya flood death toll since March climbs to 70: govt
1 hour ago -
Russia striking Ukraine railways to 'paralyse' army cargo: Ukraine source
1 hour ago -
French barber still trimming at 90
1 hour ago -
Russia striking Ukraine railways to 'paralyse' army cargo
1 hour ago -
UK man charged with 'Russia-backed arson plot' on Ukraine-linked targets
2 hours ago